Dr. Colin S. Goldschmidt, MD, is a Chief Executive Officer at Douglass Hanly Moir Pathology Pty Ltd. and a Chief Executive Officer, MD & Executive Director at Sonic Healthcare Ltd. He is on the Board of Directors at Sonic Healthcare Holding Co., Sonic Healthcare Ltd., Health Services Laboratories LLP, Sonic Healthcare USA, Inc., TDL Genetics Ltd. and The Doctors Laboratory Ltd. Dr. Goldschmidt was previously employed as a Non-Executive Director by Independent Practitioner Network Pty Ltd. and an Independent Non-Executive Director by Silex Systems Ltd.